{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:15:48Z","timestamp":1761167748213,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["F-22717-20"],"award-info":[{"award-number":["F-22717-20"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ghir.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T14:32:13Z","timestamp":1499869933000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS)"],"prefix":"10.1016","volume":"35","author":[{"given":"Mathilde Gersel","family":"Wegmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Thankamony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Hoey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guftar","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten-A.","family":"Ivarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"S\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Dunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Juul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke Beck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society","volume":"92","author":"Clayton","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2017.07.001_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000353438","article-title":"Baseline IGF-I levels determine insulin secretion and insulin sensitivity during the first year on growth hormone therapy in children born small for gestational age. Results from a north European multicentre study (NESGAS)","volume":"80","author":"Jensen","year":"2013","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"10.1016\/j.ghir.2017.07.001_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/jc.2015-3019","article-title":"Adiposity in children born small for gestational age is associated with beta-cell function, genetic variants for insulin resistance, and response to growth hormone treatment","volume":"101","author":"Thankamony","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2017.07.001_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000322878","article-title":"A comparison of different definitions of growth response in short prepubertal children treated with growth hormone","volume":"75","author":"Bang","year":"2011","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"10.1016\/j.ghir.2017.07.001_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","article-title":"Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia international growth database)","volume":"88","author":"Ranke","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0035","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.1210\/jc.2014-3469","article-title":"Genetic markers of insulin sensitivity and insulin secretion are associated with spontaneous postnatal growth and response to growth hormone treatment in short SGA children: the north European SGA study (NESGAS)","volume":"100","author":"Jensen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ghir.2017.07.001_bb0040","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ng1379","article-title":"A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone","volume":"36","author":"Dos Santos","year":"2004","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2265.2007.02911.x","article-title":"GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism","volume":"67","author":"Tauber","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2017.07.001_bb0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2265.2011.04104.x","article-title":"Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children","volume":"75","author":"Dorr","year":"2011","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2017.07.001_bb0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1210\/jc.2005-1581","article-title":"The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in turner syndrome and short small-for-gestational-age children","volume":"91","author":"Binder","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2017.07.001_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/jc.2007-1182","article-title":"Growth hormone (GH) dose, but not exon 3-deleted\/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH therapy in short small-for-gestational-age children","volume":"93","author":"Carrascosa","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ghir.2017.07.001_bb0065","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2006-0685","volume":"91","author":"Carrascosa","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2017.07.001_bb0070","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2265.2007.03140.x","article-title":"GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age","volume":"68","author":"de Graaff","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2017.07.001_bb0075","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1210\/jc.2008-0150","volume":"93","author":"Audi","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ghir.2017.07.001_bb0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/aje\/kwr408","article-title":"Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis","volume":"175","author":"Renehan","year":"2012","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.ghir.2017.07.001_bb0085","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1210\/jc.2009-0425","article-title":"Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis","volume":"94","author":"Wassenaar","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ghir.2017.07.001_bb0090","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jc.2009-0313","article-title":"Impact of the growth hormone receptor exon 3 deletion gene polymorphism on glucose metabolism, lipids, and insulin-like growth factor-I levels during puberty","volume":"94","author":"Sorensen","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2017.07.001_bb0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1530\/EJE-15-0474","article-title":"GH deficiency status combined with GH receptor polymorphism affects response to GH in children","volume":"173","author":"Valsesia","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0100","first-page":"132","article-title":"Relationship between nocturnal growth hormone concentrations, serum IGF-I\/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children","volume":"68","author":"Mericq","year":"2007","journal-title":"Horm. Res."},{"issue":"4","key":"10.1016\/j.ghir.2017.07.001_bb0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-14-0419","article-title":"A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the north European small-for-gestational-age study","volume":"171","author":"Jensen","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"25","key":"10.1016\/j.ghir.2017.07.001_bb0110","doi-asserted-by":"crossref","first-page":"18664","DOI":"10.1074\/jbc.M001615200","article-title":"Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution","volume":"275","author":"Pantel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2017.07.001_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2431-8-8","article-title":"Continuous growth reference from 24th week of gestation to 24 months by gender","volume":"8","author":"Niklasson","year":"2008","journal-title":"BMC Pediatr."},{"issue":"7","key":"10.1016\/j.ghir.2017.07.001_bb0120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1651-2227.2002.tb03322.x","article-title":"Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference","volume":"91","author":"Wikland","year":"2002","journal-title":"Acta Paediatr. (Oslo, Norway: 1992)"},{"issue":"2","key":"10.1016\/j.ghir.2017.07.001_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ijo.0801515","article-title":"Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values","volume":"25","author":"Nysom","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"5","key":"10.1016\/j.ghir.2017.07.001_bb0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1530\/EJE-12-0106","article-title":"Serum IGF1 and insulin levels in girls with normal and precocious puberty","volume":"166","author":"Sorensen","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2017.07.001_bb0135","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1210\/jc.2009-2484","article-title":"The exon 3 deleted growth hormone receptor gene is associated with small birth size and early pubertal onset in healthy boys","volume":"95","author":"Sorensen","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11102-011-0329-9","article-title":"The growth hormone receptor polymorphism in patients with acromegaly: relationship to BMI and glucose metabolism","volume":"15","author":"Turgut","year":"2012","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.ghir.2017.07.001_bb0145","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jc.2008-0391","article-title":"Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly","volume":"93","author":"Mercado","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2017.07.001_bb0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2265.2009.03703.x","article-title":"d3-growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype","volume":"72","author":"Montefusco","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2017.07.001_bb0155","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ghir.2007.04.005","article-title":"GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder","volume":"17","author":"Strawbridge","year":"2007","journal-title":"Growth Hormon. IGF Res."},{"issue":"2","key":"10.1016\/j.ghir.2017.07.001_bb0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/EJE-09-0053","article-title":"D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly","volume":"161","author":"Kamenicky","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2017.07.001_bb0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jc.2009-1630","article-title":"The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly","volume":"95","author":"Bernabeu","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2017.07.001_bb0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1530\/EJE-15-0519","article-title":"Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3","volume":"173","author":"Franck","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0175","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jc.2005-2005","article-title":"Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency","volume":"91","author":"Jorge","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2017.07.001_bb0180","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1210\/jc.2007-1382","article-title":"Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency","volume":"93","author":"Raz","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2017.07.001_bb0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2265.2007.03090.x","article-title":"Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with turner syndrome","volume":"68","author":"Binder","year":"2008","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2017.07.001_bb0190","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1210\/jc.2007-0176","article-title":"The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects","volume":"92","author":"Jensen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2017.07.001_bb0195","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/jc.2008-1337","article-title":"Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly","volume":"94","author":"Bianchi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2017.07.001_bb0200","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2217\/pgs.09.91","article-title":"Association of the exon 3 deleted\/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults","volume":"10","author":"Meyer","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ghir.2017.07.001_bb0205","article-title":"The effect of the exon-3-deleted GH-receptor in Pegvisomant-treated acromegaly: a systematic review and meta-analysis","author":"Franck","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ghir.2017.07.001_bb0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-14-0723","article-title":"The GH receptor exon 3 deleted\/full-length polymorphism is associated with central adiposity in the general population","volume":"172","author":"Glad","year":"2015","journal-title":"Eur. J. Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417300576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:50:24Z","timestamp":1761087024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637417300576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":42,"alternative-id":["S1096637417300576"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2017.07.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS)","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}